Judge: Opioid distribution data not for public consumption

July 27, 2018 by Geoff Mulvihill

A federal judge has ruled that state and local governments cannot publicize federal government data about where prescription opioids were distributed—a blow to news organizations seeking to report more deeply on the nation's overdose and addiction crisis.

The U.S. Drug Enforcement Agency is providing the to state and local governments to use in their lawsuits against companies that make, distribute and sell the drugs. Sharing the data even with them came with a long list of conditions, including that it could be used only for law enforcement and litigation.

Cleveland-based Judge Dan Polster, who is overseeing more than 800 of the lawsuits in federal court, ruled Thursday that the data cannot be made public, saying that doing so would reveal trade secrets and "eviscerate" the terms under which the information was shared.

The federal collects information on the distribution of all controlled dangerous substances.

Polster has scheduled the first trials in the matter to start in March 2019. He's been pushing in the meantime for a national settlement. The industry and government entities—including states that have not filed lawsuits—have been negotiating for months even as the cases are prepared for trial.

News organizations, including The Associated Press, had asked for the data through public records requests made to local governments.

A West Virginia judge made some of the data public in 2016. The Charleston Gazette-Mail of West Virginia used it to report that 780 million pills flowed into the state of just 1.8 million residents over a six-year period. During that time, more than 1,700 West Virginians died from overdoses of opioids, a category of drugs that includes such as OxyContin and Vicodin, and illegal ones such as heroin and illicitly made fentanyl.

HD Media, owner of The Gazette-Mail, and The Washington Post argued in legal filings that disclosing the information might embarrass companies or government agencies, but that it would provide public accountability on behalf of people harmed by opioids.

Paul Farrell, a lead lawyer for suing over the drugs, said the data would also show the public which pharmacies sold huge amounts of the drugs.

Combined, opioids killed more than 42,000 Americans in 2016, according to the U.S. Centers for Disease Control and Prevention.

Explore further: US opioid crisis at epidemic proportions

Related Stories

US opioid crisis at epidemic proportions

May 4, 2017
Many US communities are facing an epidemic of opioid and heroin abuse that is straining resources from police, to jails, to emergency medical personnel and treatment centers.

Going after opioid manufacturers, distributors in court may help with crisis

December 15, 2017
As the health care community moves on multiple fronts to address the opioid crisis, one area that holds promise is in litigation against those who manufacture and distribute prescription opioid drugs, according to a University ...

White House launches anti-opioid ad campaign aimed at youth

June 7, 2018
The White House launched a series of new advertisements Thursday aimed at warning young people about the dangers of opioids, taking another step in the effort to turn the tide against the deadly epidemic.

Opioid overdoses in ERs up 30 percent as crisis worsens

March 6, 2018
Emergency rooms saw a big jump in overdoses from opioids last year—the latest evidence the nation's drug crisis is getting worse.

6 US states accuse opioid maker Purdue of fueling overdoses

May 15, 2018
Six U.S. states on Tuesday sued the maker of the opioid OxyContin of using deceptive marketing to boost drug sales that fueled opioid overdose deaths.

Massachusetts sues opioid maker, executives over drug crisis

June 12, 2018
Massachusetts sued the maker of prescription opioid painkiller OxyContin and its executives on Tuesday, accusing the company of spinning a "web of illegal deceit" to fuel the deadly drug abuse crisis while boosting profits.

Recommended for you

Medicating distress: Risky sedative prescriptions for older adults vary widely

October 18, 2018
Despite years of warnings that older adults shouldn't take sedative drugs that put them at risk of injury and death, a new study reveals how many primary care doctors are still prescribing them, how often, and exactly where.

Medical management of opioid-induced constipation differs from other forms of condition

October 17, 2018
Traditional laxatives are recommended as first-line agents to treat patients with a confirmed diagnosis of opioid-induced constipation (OIC), according to a new guideline from the American Gastroenterological Association ...

Research assesses geographic distribution of new antibiotics following market introduction

October 16, 2018
There is a growing need for new antibiotics to help combat the looming threat of antimicrobial resistance. According to a new study conducted by researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) with ...

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

Do price spikes on some generic drugs indicate problems in the market?

October 1, 2018
A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.